Organogenesis Holdings (ORGO) EBT Margin (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly EBT Margin of 183.93% for Q1 2026, down 15419.0% year-over-year from N/an in Q1 2025, and down 754.23% quarter-over-quarter from 28.11% in Q4 2025.
Organogenesis Holdings (ORGO) EBT Margin (2017 - 2026) Analysis & Trends
Organogenesis Holdings' EBT Margin history runs 10 years deep, the most recent figure standing at 183.93% for Q1 2026.
- In Q1 2026, EBT Margin fell 15419.0% year-over-year to 183.93%; the TTM figure through Mar 2026 stood at 0.83% (up 612.0% YoY), while the FY2025 annual figure was 8.33%, up 891.0% from the prior year.
- EBT Margin for Q1 2026 stood at 183.93%, down from 28.11% in the prior quarter.
- The five-year high for EBT Margin was 28.11% in Q4 2025, with the low at 183.93% in Q1 2026.
- The 5-year median for EBT Margin is 1.04% (2022), against an average of 9.38%.
- The sharpest annual moves came in 2025 and 2026: EBT Margin jumped 2002 bps in 2025, then sank 15419 bps in 2026.
- Organogenesis Holdings' EBT Margin stood at 7.58% in 2022, then sank by 124 bps to 1.8% in 2023, then jumped by 549 bps to 8.1% in 2024, then surged by 247 bps to 28.11% in 2025, then plunged by 754 bps to 183.93% in 2026.
- Business Quant data shows ORGO's EBT Margin at 183.93% in Q1 2026, 28.11% in Q4 2025, and 14.03% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Organogenesis Holdings | 239.98 Mn | 193.13 Mn | 20.08 Mn | -116.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -116.28% |
| Mar 31, 2026 | -183.93% |
| Dec 31, 2025 | 28.11% |
| Sep 30, 2025 | 14.03% |
| Jun 30, 2025 | -11.72% |
| Mar 31, 2025 | -29.74% |
| Dec 31, 2024 | 8.10% |
| Sep 30, 2024 | 5.06% |
| Jun 30, 2024 | -11.16% |
| Mar 31, 2024 | -3.95% |
| Dec 31, 2023 | -1.80% |
| Sep 30, 2023 | 7.04% |
| Jun 30, 2023 | 7.82% |
| Mar 31, 2023 | -4.30% |
| Dec 31, 2022 | 7.58% |
| Sep 30, 2022 | 1.04% |
| Jun 30, 2022 | 9.21% |
| Mar 31, 2022 | -0.89% |
| Dec 31, 2021 | 14.77% |
| Sep 30, 2021 | 11.32% |